AU1067200A - Pharmaceutical conjugates comprising two active agents - Google Patents
Pharmaceutical conjugates comprising two active agentsInfo
- Publication number
- AU1067200A AU1067200A AU10672/00A AU1067200A AU1067200A AU 1067200 A AU1067200 A AU 1067200A AU 10672/00 A AU10672/00 A AU 10672/00A AU 1067200 A AU1067200 A AU 1067200A AU 1067200 A AU1067200 A AU 1067200A
- Authority
- AU
- Australia
- Prior art keywords
- active agents
- pharmaceutical conjugates
- conjugates
- pharmaceutical
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000013543 active substance Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9827813.8A GB9827813D0 (en) | 1998-12-17 | 1998-12-17 | Pharmaceutical conjugates |
| GB9827813 | 1998-12-17 | ||
| PCT/GB1999/003801 WO2000035487A1 (en) | 1998-12-17 | 1999-11-15 | Pharmaceutical conjugates comprising two active agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1067200A true AU1067200A (en) | 2000-07-03 |
Family
ID=10844425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU10672/00A Abandoned AU1067200A (en) | 1998-12-17 | 1999-11-15 | Pharmaceutical conjugates comprising two active agents |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU1067200A (en) |
| GB (1) | GB9827813D0 (en) |
| WO (1) | WO2000035487A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0516091D0 (en) * | 2005-08-04 | 2005-09-14 | Haemostatix Ltd | Therapeutic agent |
| CN108267577B (en) * | 2018-01-15 | 2020-10-09 | 广州市妇女儿童医疗中心 | An EV71 virus IgA antibody detection test strip |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69731985T2 (en) * | 1996-10-21 | 2005-12-29 | Quadrant Drug Delivery Ltd., Ruddington | BLANK SPARE PARTS AND SUITABLE CONJUGATION MANUFACTURING PROCESS |
| GB9724143D0 (en) * | 1997-11-14 | 1998-01-14 | Andaris Ltd | Pharmaceutical conjugate |
-
1998
- 1998-12-17 GB GBGB9827813.8A patent/GB9827813D0/en not_active Ceased
-
1999
- 1999-11-15 AU AU10672/00A patent/AU1067200A/en not_active Abandoned
- 1999-11-15 WO PCT/GB1999/003801 patent/WO2000035487A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB9827813D0 (en) | 1999-02-10 |
| WO2000035487A1 (en) | 2000-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1225000A (en) | Combined pharmaceutical estrogen-androgen-progestin | |
| AU5259100A (en) | Medicament | |
| SG115489A1 (en) | Pharmaceutically active morpholinol | |
| AU5387898A (en) | Pharmaceutical agents | |
| AU4328800A (en) | Pharmaceutical formulation | |
| AU1409100A (en) | Drugs | |
| AU6715600A (en) | Pharmaceutical formulations | |
| AU5965399A (en) | Pharmaceutically active composition | |
| AU2451500A (en) | Therapeutic agents | |
| AU4977300A (en) | Pharmaceutical formulations | |
| AU5973600A (en) | Therapeutic agents | |
| AU1385801A (en) | Pharmaceutical formulations | |
| AU1800100A (en) | Medicinal preparations | |
| AU3839900A (en) | Pharmaceutical formulation | |
| AU5182099A (en) | Pharmaceutical formulation | |
| AU1067200A (en) | Pharmaceutical conjugates comprising two active agents | |
| AU5429699A (en) | Drug targeting | |
| AU1388501A (en) | Pharmaceutical formulation | |
| AU2279800A (en) | Pharmaceutical preparation | |
| AU4504201A (en) | Drug preparations | |
| AU6150200A (en) | Therapeutic agents | |
| AUPP574298A0 (en) | Pharmaceutical preparation | |
| AU5817400A (en) | Therapeutic agents | |
| AUPP458098A0 (en) | Pharmaceutical agents | |
| AUPQ070099A0 (en) | Pharmaceutical agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |